The reasons for the greater rates of admission among SLE patients versus non-SLE patients with serious infections during the study period are not fully understood, but may relate to the more frequent use of steroids and strong immunosuppressive treatments. This also may reflect the overall increased survival of SLE patients even with comorbidities and organ damage.
http://www.medpagetoday.com/Rheumatology/Lupus/52814?xid=nl_mpt_DHE_2015-07-29&eun=g721819d0r
No comments:
Post a Comment